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Background: Polysaccharopeptide (PSP), isolated from Coriolus versicolor COV-1 strain, is a protein-bound polysaccharide
widely used as immunoadjuvant for cancer immunotherapy. Although the immunomodulatory activity of PSP has been
well established, the precise molecule mechanisms of its biological activity have yet to be fully elucidated.
Methods: In the present study, we first investigated the immunomodulatory activity of PSP in peritoneal macrophages
from C57BL/10J (TLR4+/+) and C57BL/10ScCr (TLR4-/-) mice carrying a defective toll-like receptor-4 (TLR4) gene and then
evaluated PSP for its effect on tumor inhibition rates and the immune organ index in above two different strains of mice.
In addition, PSP were also evaluated for its activation of TLR4, TLR4-downstream molecules (TRAF6, NF-κB and AP-1) in
spleens of tumor-bearing C57BL/10J (TLR4+/+) and C57BL/10ScCr (TLR4-/-) mice.
Results: The results showed that PSP had adjuvant activities in stimulating expressions of cytokines as well as TLR4,
TRAF6, phosphorylation of NF-κB p65 transcription factors and phosphorylation of c-Jun (a component of the transcription
factor AP-1) in peritoneal macrophages from C57BL/10J (TLR4+/+) mice but not from C57BL/10ScCr (TLR4-/-) mice. In vivo
PSP as well as Adriamycin (ADM) decreased the mean weights of tumors compared with normal saline and PSP increased
thymus index and spleen index relative to ADM in tumor-bearing C57BL/10J (TLR4+/+) mice but not in C57BL/10ScCr
(TLR4-/-) mice.
Conclusions: We demonstrated that PSP activates peritoneal macrophages in vitro via TLR4 signaling pathway and PSP
functions its immunoregulatory effect in vivo also via TLR4 signaling pathway. These data strongly suggest TLR4 signaling
pathway is involved in PSP-mediated immunomodulatory activities.
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Historically, Mushrooms have been considered as
important source of materials in traditional Chinese
medicine. Polysaccharide extracts from mushrooms
display immunomodulatory and anti-tumor activities
in vivo and in vitro [1–3]. Coriolus versicolor (better
known as Yunzhi in China), a medicinal fungus of the
Basidiomycetes family, has been used as a “magic herb”
for promoting good health and longevity. Its medicinal
value was recorded in the Compendium of Materia
Medica and Shen Non Compendium Medica thousands* Correspondence: yixibao@163.com
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unless otherwise stated.of years ago in China [4–6]. Polysaccharopeptide (PSP)
is a protein-bound polysaccharide extracted from the
deep-layer cultivated mycelia of C. versicolor COV-1
strain [7]. PSP, which has an approximate molecular
weight of 100KDa and is highly water-soluble, appears
to be safe during pregnancy. It did not affect ovarian
steroidogenesis, ovulation and midterm gestation in
mice [4, 8, 9]. Numerous scientific investigations have
demonstrated that PSP has anti-tumor, anti-inflammatory,
immunoregulatory and antiviral effects in vivo and
in vitro [5, 10–12]. PSP was also found to restore a
depressed immunological responsiveness in patients
suffering from cancer or in chemotherapy [13, 14].This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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in those functions have not been clearly elucidated.
Recent researches indicated that the immunoregula-
tory effects of polysaccharides are related to the Toll-like
receptors (TLR) signaling pathway [15, 16], and Toll-like
receptors 4 (TLR4) plays a central role in the enhance-
ment of the innate immune response and the production
of cytokine induced by polysaccharides [17–20]. A family
of TLRs plays an important role in the recognition of
molecular structures that are shared by many pathogens
in the host defense system [21, 22]. TLR4 is the first
mammalian homologue of the Drosophila Toll protein
[23] and recognizes lipopolysaccharide (LPS) from
Gram-negative bacteria, which causes septic shock [24,
25]. Further study indicates that TLR4 is the immune
receptor of both Ganoderma lucidum polysaccharides
(GLPS) and polysaccharides from Astragalus membra-
naceus [26, 27]. In addition, our previous studies have
reported that PSP has an immunoregulatory effect
through the TLR4 signaling pathway in human peripheral
blood mononuclear cells (PBMCs) [28].
To further elucidate the molecular mechanisms for the
immunoregulatory function of PSP, based on previous
evidences, we focused on investigating the role of TLR4
and TLR4 signaling pathway in the PSP-mediated immu-
nomodulation activities. In this paper, C57BL/10ScCr
mice (TLR4-defect mice lacking functional TLR4),
C57BL/10 J mice (wild-type mice with functional TLR4)
and the peritoneal macrophages isolated from these two
strains were used to demonstrated the immunomodula-
tion mechanism of PSP mediated by TLR4 signaling
pathway both in vitro and in vivo.
Results
PSP-induced activation of macrophages through TLR4
The activation of macrophages facilitates the production
of many immunomodulatory substances including cyto-
kines. In order to verify if TLR4 was required for PSP
activation of macrophages, peritoneal macrophages from
ScCr (TLR4−/−) and B10 (TLR4+/+) mice were incubated
with PSP (25 μg/ml) or LPS (100 ng/ml) as a positiveFig. 1 PSP-induced TNF-α and IL-6 production by mouse peritoneal macroph
were treated with PSP (25 μg/ml) or LPS (100 ng/ml) for 24 h. TNF-α (a) or IL-
by ELISA. Data represent the mean ± SD of three experiments. *p < 0.05 vs. cocontrol for 24 h and then assayed for TNF-α and IL-6
concentration in their culture supernatant. As shown in
Fig. 1, both LPS and PSP induced TNF-α secretion by
peritoneal macrophages from wild-type control B10
mice but did not induce TNF-α secretion in ScCr mice
lacking functional TLR4 (Fig. 1a). Similarly, LPS and
PSP failed to induce IL-6 secretion in ScCr mice
(Fig. 1b). These results suggest that TLR4 is involved in
PSP activation of murine macrophages.
Effect of PSP on activation of TLR4 signaling pathway in
peritoneal macrophages from B10 (TLR4+/+) and ScCr
(TLR4−/−) mice
TLR4 activates intracellular signaling pathways that lead
to the induction of cytokines, such as TNF-α and IL-6
[29, 30]. To elucidate TLR4 signaling pathway involved
in PSP-mediated macrophage activation, we examined
activation of TLR4, TLR4-downstream molecules
(TRAF6, NF-κB and AP-1) in TLR4+/+ and TLR4−/−
peritoneal macrophages at protein level. After incuba-
tion with PSP (25 μg/ml) or LPS (100 ng/ml) for 12 h
in 5 % CO2 at 37 °C, western blot was performed. As
shown in Fig. 2, the protein levels of TLR4 and TRAF6
were upregulated in PSP and LPS group compared
with control group in peritoneal macrophages of B10
(TLR4+/+) mice (all p < 0.05). The phosphorylation
levels of transcription factors NF-κB (p65 subunit) and
AP-1 (P-c-Jun) were likewise significantly higher in
PSP and LPS group than control group in peritoneal
macrophages of B10 (TLR4+/+) mice (all p < 0.05). No
significant differences in those protein expressions
were found between groups in ScCr (TLR4−/−) mice,
suggesting that the activation was dependent on TLR4
signaling pathway.
General state of tumor-bearing mice
After administration, there was no abnormality seen
daily in the autonomic activities, behavior, ingestion,
pelage, feces, and urine of mice in each group. Also,
there were no abnormal secretion in the eye, ear, nose,
and mouth.ages. B10 (TLR4+/+) and ScCr (TLR4−/−) mouse peritoneal macrophages
6 (b) concentration (pg/ml) in the culture supernatant was determined
ntrol (B10). #p < 0.05 vs. PSP (B10)
Fig. 2 PSP-mediated activation of TLR4, TRAF6, NF-κB and AP-1 in B10 (TLR4+/+) and ScCr (TLR4−/−) peritoneal macrophages. Peritoneal macrophages
from B10 (TLR4+/+) and ScCr (TLR4−/−) mice were cultured with PSP (25 μg/ml) or LPS (100 ng/ml) for 12 h. The levels of TLR4 (a), TRAF6 (b), P- NF-κB
p65 (c) and P-c-Jun (d) were examined by Western blot. Data represent the mean ± SD of three experiments. *p < 0.05 vs. control group.
ND= not detected
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organ index in B10 (TLR4+/+) and ScCr (TLR4−/−)
tumor-bearing mice
In vivo immunoregulatory and anti-tumor activities of
PSP were examined in B10 (TLR4+/+) or ScCr (TLR4−/−)
mice inoculated with Ehrlich’s ascites carcinoma (EAC)
cells. Twenty five days after inoculation, the meanweights of tumors in B10 (TLR4+/+) tumor-bearing mice
that received PSP and ADM treatment were significantly
decreased compared with those in the saline group (all
p < 0.05). The inhibition rates of ADM group and PSP
group were 40.67 % and 29.64 %. In ScCr (TLR4−/−)
mice, the mean weights of tumors in the ADM group
were decreased significantly compared with those in the
Wang et al. BMC Immunology  (2015) 16:34 Page 4 of 9saline group (p < 0.05),however, there were no signifi-
cant change trends between PSP group and saline
group (Fig. 3a). Furthermore, in B10 (TLR4+/+) tumor-
bearing mice, the thymus index in the ADM group
decreased significantly, as compared with that in the
saline group (p < 0.05). Both the thymus index and
spleen index in the PSP group increased significantly
relative to that in the ADM group (all p < 0.05).
However, there were no significant differences of the
thymus index and spleen index among groups in ScCr
(TLR4−/−) mice (Fig. 3b and c).
TLR4 expression and signaling in spleens of B10 (TLR4+/+)
and ScCr (TLR4−/−) mice exposed to PSP
The signaling pathway mediated by TLR4 has been
implicated in the response to PSP in vitro. To clarify
whether TLR4 signaling pathway is involved in PSP-
mediated immunomodulation in vivo, we studied the
expression at mRNA and protein level of TLR4, TRAF6,
NF-κB and AP-1 in the spleen of B10 (TLR4+/+) and
ScCr (TLR4−/−) mice. Twenty five days after administration,
TLR4, TRAF6, NF-κB and AP-1 in PSP and LPS group
(positive control) were significantly increased at mRNA and
protein level relative to those of the saline group in the
spleen of B10 (TLR4+/+) tumor-bearing mice (all p < 0.05).
As expected, there were no significant differences in the
expressions of TLR4, TRAF6, NF-κB and AP-1 among
groups in ScCr (TLR4−/−) mice (Fig. 4).Fig. 3 The tumor weight (g) and the tumor inhibition rate (%) of each gro
index of each group (b), The spleen index of each group (c). Data repre
#p < 0.05 vs. ADM groupDiscussion
PSP is well-known for its immunoregulatory effect,
attaining widespread usage as therapeutic adjuvant for
cancer immunotherapy in China and Japan [4]. Previous
studies have indicated that PSP could significantly in-
crease the percentage of CD4+ T lymphocytes, the ratio
of CD4+/CD8+ and the quantity and percentage of the B
lymphocytes and finally enhanced the immune system of
cancer patients [14, 31]. However, studies concerning
the underlying mechanisms involved in PSP-mediated
immunomodulation effects are very limited. Our previ-
ous study demonstrated that PSP has an immunoregula-
tory effect through the TLR4 signaling pathway in
PBMCs from breast cancer patients [28].
The role of TLR4 in Gram-negative bacterial LPS-
mediated signaling has been studied extensively [32, 33].
Our current results indicated that both PSP and LPS
transduces part of signalings via the TLR4, but the
biological outcomes are quite different. Interestingly,
PSP has been used to promote health in many Asian
countries, but concentrated LPS of contaminated
bacteria causes high mortality in vitro or in vivo [19].
However, the molecular mechanisms for PSP or LPS in
the differential immunity outcomes are not clear.
In our study, to delineate the signaling pathway in-
volved in PSP-mediated immunomodulation in vitro,
peritoneal macrophages from ScCr (TLR4−/−) and B10
(TLR4+/+) mice were used. Macrophages, which provideup (a); the indexes of immune organs in each group: The thymus
sent the mean ± SD; n = 4-6 mice/ group. *p < 0.05 vs. saline group;
Fig. 4 PSP-induced changes in TLR4, TRAF6, NF-κB and AP-1 expressions in spleens of B10 (TLR4+/+) and ScCr (TLR4−/−) tumor-bearing mice. The
mRNA level of TLR4 (b), TRAF6 (d), NF-κB (f) and AP-1 (h) in spleens of B10 (TLR4+/+) and ScCr (TLR4−/−) mice were measured by Q-PCR. The
protein level of TLR4 (a), TRAF6 (c), NF-κB (e) and AP-1 (g) were tested by Western blot. Data represent the mean ± SD; n = 4-6 mice/ group.
*p < 0.05 vs. saline group. ND = not detected
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munity, play critical roles in host defense, including
phagocytosis of pathogens and apoptotic cells, produc-
tion of cytokines, and proteolytic processing and presen-
tation of foreign antigens [34, 35]. The activation of
macrophages facilitates the production of many immu-
nomodulatory substances including cytokines, such as
TNF-α, IL-6 and IFN-γ, which are known to play an
important role in suppressing tumor cells. Indeed, a
variety of plant polysaccharides have been shown to
possess immunomodulatory activity through their ability
to modulate macrophage function [36]. When incubated
with PSP (25 μg/ml) and LPS (100 ng/ml) for 24 h, peri-
toneal macrophages from B10 (TLR4+/+) mice increased
their production of TNF-α and IL-6. However, produc-
tion of TNF-α and IL-6 in PSP and LPS stimulated
peritoneal macrophages from ScCr (TLR4−/−) was
significantly reduced (Fig. 1). Moreover, PSP and LPS
upregulated the expressions of TLR4 and TLR4-
downstream molecules (TRAF6, Phospho-NF-κB p65 and
Phospho-c-Jun) in B10 (TLR4+/+) peritoneal macrophages
but not in ScCr (TLR4−/−) peritoneal macrophages (Fig. 2).
As TLR4 recognizes LPS from most Gram-negative
species, LPS was used as the prototypical TLR4 agonist to
provide a positive reference. These results suggest that
TLR4 signaling pathway is involved in PSP-induced activa-
tion of macrophages in vitro.
To verify whether TLR4 signaling pathway is involved
in PSP-mediated immunomodulation in vivo, we found
PSP and ADM treatment significantly decreased the
mean weights of tumors than saline treatment in B10
(TLR4+/+) tumor-bearing mice (Fig. 3a). At the same
time, PSP administration significantly increased the
thymus index and spleen index relative to ADM
administration in B10 (TLR4+/+) mice (Fig. 3b and c).
However, these significant changes were not observed
in ScCr (TLR4−/−) tumor-bearing mice (Fig. 3). These
results indicate that PSP could inhibit tumor growth
and alleviate the decrease of thymus and spleen in-
duced by ADM via TLR4 signaling pathway.
In vivo, the activation of TLR4 and TLR4-downstream
molecules (TRAF6, NF-κB and AP-1) in spleens of B10
(TLR4+/+) and ScCr (TLR4−/−) tumor-bearing mice were
measured by Q-PCR and Western blot. In Q-PCR
experiments, Vandesompele method, which is more ad-
vanced than the Pfaffl method, was applied to analyze
these data. The Vandesompele method normalizes not
only with the adjusted PCR efficiency but also with
multiple genes. β-actin and GAPDH were used as refer-
ence genes to assay the relative mRNA expression
levels. LPS was used as positive reference like in vitro
study. From the results, we found that the mRNA and
protein levels of TLR4, TRAF6, NF-κB and AP-1 were
significantly upregulated by PSP as well as LPS inspleens of B10 (TLR4+/+) tumor-bearing mice (Fig. 4).
At the same time, these significantly differences were
not observed in ScCr (TLR4−/−) mice (Fig. 4).Conclusions
In summary, our present study demonstrated that PSP
activates peritoneal macrophages in vitro via TLR4 sig-
naling pathway and PSP functions its immunoregulatory
effect in vivo also via TLR4 signaling pathway. These
data strongly suggest TLR4 signaling pathway is involved
in PSP-mediated immunomodulatory activities.Methods
Animals
Female 4–6 weeks old C57BL/10ScCr (ScCr, TLR4−/−)
and C57BL/10 J (B10, TLR4+/+) mice (Permit number:
scxk 2010–0001), weighing 16-20 g, were purchased
from Model Animal Research Center of Nanjing
University (Nanjing, China). The C57BL/10ScCr murine
strain has a homozygous deletion of 74,723 bp at the
tlr4 locus, removing all three exons, which abolishes the
response to LPS in these mice [24]. The C57BL/10 J
murine strain was used as the wild-type control group.
Both strains will be described as ScCr and B10
throughout the article. All experiments were followed
the protocols approved by the Animal Care and Use
Committee of the Second Affiliated Hospital of
Chongqing Medical University.Preparation of PSP solution
PSP, isolated from Coriolus versisicolor COV-1, was
obtained from Jiangsu shenhua pharmaceutical Co., LTD
(Jiangsu, China). It was characterized as previously
described [28]. Gram-negative bacterial endotoxin level
of the PSP was measured by using chromogenic end-
point tachypleus amebocyte lysate (CE TAL) assay kit
(Chinese Horseshoe Crab Reagent Manufactory Co.,
Ltd., Xiamen, China) according to the manufacturer’s
instruction in our previous study, the results showed
that very low endotoxin level (below 0.34 EU/ml) was
found in PSP at 100 μg/ml, indicating that endotoxin
contamination in PSP was negligible [28]. In our study,
PSP was dissolved in physiological saline for in vivo
experiments or in plain RPMI-1640 medium (HyClone,
Thermo scientific, USA), sterilized by passing through a
0.22-μm filter (Millipore, USA) and stored at −20 °C for
future use.Preparation of tumor cells
Ehrlich’s ascites carcinoma (EAC) cells were purchased
from Nanjing KeyGEN biotech Co., Ltd. (Nanjing, China),
cultured and passaged in abdominal cavity of mice.
Table 1 Sequence and useful information of primers designed for detection of mRNA
Gene symbol Genbank accession no. Primer sequence (5’→ 3’) Product size (bp) Annealing temperature E (%) R2
TLR4 NM_021297.2 F ctgggtgagaaatgagctggtaa 122 58 °C 96.5 0.999
R agccttcctggatgatgttgg
TRAF6 NM_009424 F catcttcagttaccgacagctcag 131 58 °C 95.2 0.999
R tggtcgagaattgtaaggcgtat
NF-κB NM_008689.2 F ccaaagaaggacacgacagaatc 127 58 °C 95.5 0.999
R ggcaggctattgctcatcaca
AP-1 NM_010591.2 F gccctggctgaactgcatag 180 58 °C 91.4 0.998
R gaagttgctgaggttggcgta
GAPDH NM_008084.2 F gacatcaagaaggtggtgaagc 117 58 °C 96.2 0.999
R gaaggtggaagagtgggagtt
β-Actin NM_007393.3 F agattactgctctggctcctagc 147 58 °C 93.6 0.998
R actcatcgtactcctgcttgct
F Forward primer, R Reverse primer, E Amplification efficiency, R2 Correlation coefficient
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Peritoneal macrophages were obtained from ScCr and
B10 mice by intraperitoneal injection of sterile thiolgly-
collate medium. Four days after injection peritoneal
macrophages were harvested from mice.
Modeling of the tumor-bearing mice
Murine EAC cells were cultured in the abdominal cavity
of mice for 7–8 days. They were taken out from the
ascites, diluted to the concentration of 1 × 107cells ml−1
with sterilized physiological saline. Then 0.1 mL EAC
cell suspension was inoculated subcutaneously to the
right armpit of each mouse. Generally, the solid tumor
could be palpated after 7–10 days with an achievement
ratio of nearly 100 %. After inoculation, each mouse was
weighed immediately. After 24 h, intraperitoneal injec-
tion and intragastric administration were carried out
simultaneously.
Experimental design
For in vitro experiments, the cultured peritoneal macro-
phages from ScCr and B10 mice were treated with PSP
(25 μg/ml) or LPS (100 ng/ml) from Escherichia coli
O55:B5 (L6529, sigma, USA) for an indicated time
period. The supernatants were harvested for detection of
cytokine levels and the cell lysates were collected for
Western blotting analysis.
For in vivo experiments, ScCr and B10 mice were used
to establish the EAC tumor-bearing model. ScCr and
B10 tumor-bearing mice were randomly assigned into
eight groups. Mice in ScCr saline group and B10 saline
group were orally administered with saline for 25 days.
Mice in ScCr Adriamycinc (ADM) group and B10 ADM
group were treated with 5.33 mg/kg/d ADM (Actavis
Italy S.p.A, ITA) through peritoneal injection for the first
3 days, followed by 22 days of saline administration.Mice in ScCr PSP group and B10 PSP group were
given PSP (500 mg/kg/d) by oral route for 25 days.
Mice in ScCr LPS group and B10 LPS group were
orally administered with saline for 25 days and then
intraperitoneally injected with LPS (5 mg/kg) 4 h
before sacrificed [37]. Twenty-five days after adminis-
tration, mice were killed by cervical dislocation. The
whole body, tumor, spleen and thymus were weighed
immediately to calculate the tumor inhibition rate and
the immune organ index. The spleen tissue samples
were extracted, immediately frozen in liquid nitrogen
and then stored at −80 °C for Q-PCR and Western
blot analyses.Cytokine analysis
Mouse peritoneal macrophages from ScCr and B10 mice
were plated in 24-well plates at a density of 2.5 × 105
cells/well and treated with or without PSP (25 μg/ml) or
LPS (100 ng/ml) as a positive control. Cells were incu-
bated for 24 h at 37 °C in 5 % CO2. Culture supernatants
were then collected for determining cytokine concentra-
tions using Mouse TNF-α and IL-6 ELISA kits (4abio,
China) according to the manufacturer’s instructions.Tumor inhibition rate and the immune organ index
The tumor inhibition rate and the immune organ
index were calculated as described previously [13].
Briefly, the inhibition rates of growth of EAC solid
tumor were calculated according to the formula:
inhibition rate (%) = (1- mean weight of tumor in
administration groups/ mean weight of tumor in the
saline group) × 100%. The organ indexes of spleen
and thymus were calculated according to the formula:
organ index (%) = mean weight of organ / body
weight × 100%.
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Total RNA in spleen homogenates was extracted via
RNAiso Plus (Takara, Japan) and reversed transcribed
into cDNA with PrimeScriptTM RT reagent Kit with
gDNA Eraser (Takara, Japan) according to the manufac-
turer’s instructions. Q-PCR was performed on Bio-Rad
CFX-96 (Bio-Rad, Foster City, CA, USA), using SYBR®
Premix Ex TaqTM II (Takara, Japan). GAPDH and β-
actin served as endogenous normalization control (refer-
ence genes). The relative expression of mRNA was
calculated by Vandesompele Method. The sequences
and related information of the Q-PCR primers are
shown in Table 1. Amplification began with initial
denaturation for 30 s at 95 °C followed by 40 cycles of
denaturation at 95 °C for 5 s, annealing and extension at
58 °C for 30 s and then the plate was read. To analyze
the specificity of the products, a melt curve procedure
was added on Bio-Rad CFX96. Triplicate reactions were
run per sample.
Western blot analysis
Mouse peritoneal macrophages and spleen tissues were
prepared for Western blot analysis. Protein concentra-
tions were measured by BCA assay (Beyotime, Jiangsu,
China), and were separated SDS-PAGE gels and trans-
ferred onto PVDF membranes (Millipore, USA). The
membranes were blocked and incubated sequentially
overnight at 4 °C with antibodies and β-actin.
Statistical analysis
All values were expressed as means ± standard deviation
(SD). Statistical differences between the experimental
groups were examined by ANOVA followed by and ana-
lyzed by post hoc Student’s Newman-Keuls test with
SPSS software (SPSS 18.0). Differences with P values of
<0.05 were considered significant.
Abbreviations
PSP: Polysaccharopeptide; TLR4: Toll-like receptors 4; PBMCs: Peripheral blood
mononuclear cells; EAC: Ehrlich’sascites carcinoma; ADM: Adriamycin;
GLPS: Ganoderma lucidum polysaccharides; IRF5: Interferon regulatory factor
5; NF-κB: Nuclear factor-κB; TRAF6: TNF receptor-associated factor 6;
ERK: Extracellular signal-regulated kinase; P38: p38 MAP kinase; JNK: c-Jun
N-terminal kinase; AP-1: Activator protein-1; LRR: Leucine rich repeats;
PAMPs: Pathogen-associated molecular patterns; TIR: Toll/IL-1 receptor;
LPS: Lipopolysaccharide; MyD88: Myeloid differentiation factor 88; TRIF: TIR
domain-containing adaptor inducing IFN-β; MAPK: Mitogen-activated protein
kinase.
Competing interests
All authors have read and approved the manuscript for submission. Neither
the manuscript nor its portions have been published previously or are under
consideration for publication elsewhere. The authors declare to have no
competing interests.
Authors’ contributions
ZW, BD, ZF, SY carried out experiments, analyzed data and performed the
statistical analysis. ZW, BD and YB conceived of the study, and participated in
its design and coordination and helped to draft the manuscript. All authors
read and approved the final manuscript.Acknowledgments
This study was supported by the funds of National Natural Science
Foundation of China (NO. 81274144 and 81473388), and was carried out at
the Experimental Animal Center of Chongqing Medical University and the
Central Laboratory in the Second Affiliated Hospital of Chongqing Medical
University.
Received: 26 November 2014 Accepted: 20 May 2015References
1. Reshetnikov SV, Wasser SP, Tan KK. Higher Basidiomycota as a source of
antitumor and immunostimulating polysaccharides. Int J Med Mushrooms.
2001;3:361–94.
2. Tzianabos AO. Polysaccharide immunomodulators as theurapeutic agents:
structural aspects and biological function. Clin Microbiol Rev.
2000;13:523–33.
3. Ooi VEC, Liu F. A review of pharmacological activities of mushroom
polysaccharides. Int J Med Mushrooms. 1999;1:195–206.
4. Ng TB. A review of research on the protein-bound polysaccharide
(polysaccharopeptide, PSP) from the mushroom Coriolus versicolor
(Basidiomycetes: Polyporaceae). Genl Pharmacol-Vasc S. 1998;30:1–4.
5. Kidd PM. The use of mushroom glucans and proteoglycans in cancer
treatment. Altern Med Rev. 2000;5:4–27.
6. Wasser SP, Weis AL. Therapeutic effects of substances occurring in higher
Basidiomycetes mushrooms: a modern perspective. Crit Rev in Immunol.
1999;19:65–96.
7. Yang MMP, Chen Z, Kwok JSL. The anti-tumor effect of a small polypeptide
from Coriolus vericolor (SPCV). Am J Chin Med. 1992;20:221–32.
8. Cui J, Chisti Y. Polysaccharopeptides of Coriolus versicolor: physiological
activity, uses, and production. Biotechnol Adv. 2003;21:109–22.
9. Ng TB, Chan WY. Polysaccharopeptide from the mushroom Coriolus versicolor
possesses analgesic activity but does not produce adverse effects on female
reproductive or embryonic development in mice. Genl Pharmacol-Vasc S.
1997;29:269–73.
10. Wang HX, Ng TB. Examination of lectins, polysaccharide, alkaloid, coumarin
and trypin inhibitors for inhibitory activity against human
immunodeficiency virus reverse transcriptase and glycohydrolases. Planta
Med. 2001;67:669–72.
11. Wan JM, Sit WH, Louie JC. Polysaccharopeptide enhances the anticancer
activity of doxorubicin and etoposide on human breast cancer cells
ZR-75-30. Int J Oncol. 2008;32:689–99.
12. Wong C, Tse P, Wong E, Leung P, Fung K, Lam C. Immunomodulatory
effects of Yun Zhi and Danshen capsules in health subjects–a randomized,
double-blind, placebo-controlled, crossover study. Int Immunopharmacol.
2004;4:201–11.
13. Li J, Bao Y, Lam W, Li W, Lu F. Immunoregulatory and anti-tumor effects of
polysaccharopeptide and Astragalus polysaccharides on tumor-bearing
mice. Immunopharmacol Immunotoxicol. 2008;30:771–82.
14. Bao YX, Wong CK, Leung SF, Chan ATC, Li PW. Clinical studies of
immunomodulatory activities of Yunzhi-Danshen in patients with
nasopharyngeal carcinoma. J Altern Complement Med. 2006;12:771–6.
15. Han S, Yoon Y, Ahn H, Lee H, Lee C. Toll-like receptor-mediated activation
of B cells and macrophages by polysaccharide isolated from cell culture of
Acanthopanax senticosus. Int Immunopharmacol. 2003;3:1301–12.
16. Lin KI, Kao YY, Kuo HK, Yang WB, Chou A. Reishi polysaccharides induce
immunoglobulin production through the TLR4/TLR2-mediated induction of
transcription factor Blimp-1. J Biol Chem. 2006;281(34):24111–23.
17. Yoon YD, Han SB, Kang JS, Lee CW, Park SK. Toll-like receptor 4-dependent
activation of macrophages by polysaccharide isolated from the radix of
Platycodon grandiflorum. Int Immunopharmacol. 2003;3:1873–82.
18. Ando I, Tsukumo Y, Wakabayashi T, Akashi S, Miyake K. Safflower
polysaccharides activate the transcription factor NF-κB via Toll-like receptor
4 and induce cytokine production by macrophages. Int Immunopharmacol.
2002;2:1155–62.
19. Hsu HY, Hua KF, Lin CC, Lin CH, Hsu J, Wong CH. Extract of Reishi
polysaccharides induces cytokine expression via TLR4-modulated protein
kinase signaling pathways. J Immunol. 2004;173:5989–99.
20. Yin X, Chen L, Liu Y, Yang J, Ma C. Enhancement of the innate immune
response of bladder epithelial cells by Astragalus polysaccharides through
Wang et al. BMC Immunology  (2015) 16:34 Page 9 of 9upregulation of TLR4 expression. Biochem Biophys Res Commun.
2010;397:232–8.
21. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate
immune response. Nature. 2000;406:782–7.
22. Imler JL, Hoffmann JA. Toll receptors in innate immunity. Trends Cell Biol.
2001;11:304–11.
23. Medzhitov R, Preston-Hurlburt P, Janeway CA. A human homologue of the
Drosophila Toll protein signals activation of adaptive immunity. Nature.
1997;388:394–7.
24. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C. Defective LPS signaling
in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science.
1998;282:2085–8.
25. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity.
Cell. 2006;124:783–801.
26. Shao BM, Xu W, Dai H, Tu P, Li Z, Gao XM. A study on the immune
receptors for polysaccharides from the roots of Astragalus membranaceus, a
Chinese medicinal herb. Biochem Biophys Res Commun. 2004;320:1103–11.
27. Shao BM, Dai H, Xu W, Lin ZB, Gao XM. Immune receptors for
polysaccharides from Ganoderma lucidum. Biochem Biophys Res Commun.
2004;323:133–41.
28. Wang J, Dong B, Tan Y, Yu S, Bao YX. A study on the immunomodulation
of polysaccharopeptide through the TLR4-TIRAP/MAL-MyD88 signaling
pathway in PBMCs from breast cancer patients. Immunopharmacol
Immunotoxicol. 2013;35:497–504.
29. Zeytun A, Chaudhary A, Pardington P. Induction of cytokines and chemokines
by Toll-like receptor signaling: strategies for control of inflammation. Crit Rev
Immunol. 2010;30:53–67.
30. Schaefer TM, Desouza K, Fahey JV. Toll-like receptor (TLR) expression and
TLR-mediated cytokine/chemokine production by human uterine epithelial
cells. Immunology. 2004;112:428–36.
31. Wong CK, Bao YX, Wong E, Leung PC, Fung KP, Lam C. Immunomodulatory
activities of Yunzhi and Danshen in post-treatment breast cancer patients.
Am J Chin Med. 2005;33:381–95.
32. Hsu HY, Wen MH. Lipopolysaccharide-mediated reactive oxygen species
and signal transduction in the regulation of IL-1 gene expression. J Biol
Chem. 2002;277:22131.
33. Pålsson-McDermott EM, O’Neill LA. Signal transduction by the
lipopolysaccharide receptor, Toll-like receptor-4. Immunology.
2004;113:153–62.
34. Marcato LG, Ferlini AP, Bonfim RC, Ramos-Jorge ML, Ropert C. The role of
Toll-like receptors 2 and 4 on reactive oxygen species and nitric oxide
production by macrophage cells stimulated with root canal pathogens.
Oral Microbiol Immunol. 2008;23:353–9.
35. Hume DA. The mononuclear phagocyte system. Curr Opin Immunol.
2006;18:49–53.
36. Schepetkin IA, Quinn MT. Botanical polysaccharides: macrophage
immunomodulation and therapeutic potential. Int Immunopharmacol.
2006;6:317–33.
37. Aziz M, Jacob A, Matsuda A, Wu R, Zhou M. Pre-treatment of recombinant
mouse MFG-E8 downregulates LPS-induced TNF-α production in macrophages
via STAT3-mediated SOCS3 activation. PLoS One. 2011;6:e27685.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
